Nanoenhanced hydrogel system with sustained release capabilities

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 7, 2015, Pages 2416-2426

  Karnik, Sonali ^a   Hines, Kanesha ^a   Mills, David K ^a  

^a LOUISIANA TECH UNIVERSITY   (United States)

Author keywords

growth factors; halloysite nanotubes; osteoblasts; sustained release; tissue repair

Indexed keywords

BIOSYNTHESIS; CELL PROLIFERATION; KAOLINITE; MINERALOGY; NANOCOMPOSITES; NANOTUBES; OSTEOBLASTS; PROTEINS; REPAIR; SURFACE TOPOGRAPHY; TISSUE; TISSUE REGENERATION; YARN;

BONE MORPHOGENETIC PROTEINS; GROWTH FACTOR; HALLOYSITE NANOTUBES; OSTEOBLAST DIFFERENTIATION; PHENOTYPIC EXPRESSION; SUSTAINED RELEASE; THREE GROWTH FACTORS; TISSUE REPAIR;

HYDROGELS;

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; HALLOYSITE NANOTUBE; NANOCOMPOSITE; NANOTUBE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; HYDROGEL;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CELLS BY BODY ANATOMY; CONTROLLED STUDY; DRUG RELEASE; HYDROGEL; MINERALIZATION; OSTEOBLAST; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; STAINING; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; TISSUE REGENERATION; TISSUE REPAIR; VON KOSSA STAINING; ANIMAL; CELL CULTURE; DELAYED RELEASE FORMULATION; NANOTECHNOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; HYDROGELS; NANOTECHNOLOGY;

EID: 84921781925     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35376     Document Type: Article

References (63)

1. Parenteau-Bareil R, Gauvin R, Berthod F., Collagen-based biomaterials for tissue engineering applications. Materials 2010; 3: 1863-1887.
2. Ungaro F, Biondi M, Indolfi L, De Rosa G, La Rotonda M, Quaglia F, Netti P., Bioactivated polymer scaffolds for tissue engineering. In:, Ashammakhi N, Reis RL, editors. Topics in Tissue Engineering, Vol. 2; 2005.
3. Sohier J, van Blitterswilk ML, De Groot K, Bezemer JM., Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering. Exp Opin Drug Deliv 2008; 5: 543-566.
4. Sauter T, Weigle T, Kratz K, Lendlein A., Polymer scaffolds for regenerative therapies- Design of hierarchically organized structures, and, their morphological, characterization. Nano LIFE 2012; 2:1230005.
5. Tamayol A, Akbari M, Annabi N, Paul A, Khademhosseini A, Juncker D., Fiber-based tissue engineering: Progress, challenges, and opportunities. Biotech Adv 2013; 21: 669-687.
6. Nichol JW, Khademhosseini A., Modular tissue engineering: Engineering biological tissues from the bottom up. Soft Mater 2009; 5: 1312-1319.
7. Lutolf MP, Hubbell JA., Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23: 47-55.
8. Sun G, Mao JJ., Engineering dextran-based scaffolds for drug delivery and tissue repair. Nanomedicine 2012; 7: 1771-1784.
9. Pagliari S, Romanazzo S, Mosquiera D, Pinto-do-O P, Aoyag T, Forte G., Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair. Curr Med Chem 2013; 20: 3429-3447.
10. Sezer AD., Recent Advances in Novel Drug Delivery Systems. ISBN 978-953-51-0810-8: InTech; 2012. p 512.
11. 11)., Patravale V, Dandekar P, Jain R., Nanoparticulate Drug Delivery, 1st ed, ISBN 9781907568985: Woodhead Publishing; 2012. p 244.
12. Bindu S, Ashok V, Chatterjee A., Review on hydrogels as drug delivery in the pharmaceutical field. Int J Pharm Chem Sci 2012; 1: 642-661.
13. Ganji F, Vasheghani-Farahani E., Hydrogels in controlled drug delivery systems. Iranian Poly J 2009; 18: 63-68.
14. Kamoun E., Alginate Hydrogel as Drug Delivery System: Preparation of Alginate Hydrogel and its Application as Drug Delivery System. VDM Verlag Dr. Muller; 2010.
15. Prabakaran M, Mano JF., Chitosan-based particles as controlled drug delivery systems. Drug Deliv 2005; 12: 41-57.
16. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA., Hydrogels in regenerative medicine. Adv Mater 2009; 21: 3307-3329.
17. Sohier J, van Blitterswilk ML, De Groot K, Bezemer JM., Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering. Exp Opin Drug Deliv 2008; 5: 543-566.
18. Lvov YM, Shchukin DG, Möhwald H, Price RR., Halloysite clay nanotubes for controlled release of protective agents. ACS Nano 2008; 2: 814-820.
19. Abdullayev E, Price RR, Shchukin DG, Lvov TM, Möhwald H, Price RR., Halloysite tubes as nanocontainers for anticorrosion coating with benzotriazole. Appl Mater Interfaces 2009; 1: 437-443.
20. Wei W, Abdllayev E, Goeders A, Hollister A, Mills DK, Lvov YM., Clay nanotube/poly(methyl methacrylate) bone cement composite with sustained antibiotic release. Macromol Mater Eng RCS Adv 2012; 4: 488-494.
21. Veerabardran NG, Price RR, Lvov YM, Clay nanotubes for encapsulation and sustained release of drugs. Nano 2007;2: 115-120.
22. Lvov YM, Shchukin DG, Mohwald H, Price RR., Halloysite clay nanotubes for controlled release of protective agents. ACS Nano 2008; 2: 814-820.
23. Price RR, Gaber BP, Lvov Y,. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J Microencapsul 2001; 18: 713-722.
24. Wenbo W, Minullina R, Abdullayev E, Fakhrullin R, Mills DK, Lvov Y., Enhanced efficiency of antiseptics with sustained release from clay nanotubes. RSC Advances 2013; 4: 488-494.
25. Wei W, Abdllayev E, Goeders A, Hollister A, Lvov YM, Mills K. Clay nanotube/poly(methyl methacrylate) bone cement composite with sustained antibiotic release. Macromol Mater Eng 2012; 297: 645-653.
26. Abdllayev E, Lvov Y., Functional polymer clay nanotube composites with sustained release of chemical agents. Prog Polym Sci 2013; 38: 1690-1719.
27. Urist MR., Bone: Formation by autoinduction. Science 1965;12: 893-899.
28. Marie PJ, Debiais F, Hay E., Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 2002; 17: 877-885.
29. Wozney JM, Rosen V, Bryne M, Celeste AJ, Moustsatos I, Wang EA., Growth factors influencing bone development. J Cell Sci Suppl 1990; 13: 149-156.
30. Nakashima M, Reddi AH., The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 2003; 21: 1025-1032.
31. Bessa PC, Casal M, Reis RL., Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2: 1-13.
32. Khan SN, Lane JM., The use of recombinant bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Exp Opin Biol Ther 2004; 4: 741-748.
33. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach P, Franceschi R., Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 1999; 14: 893-903.
34. Weinand C, Xu JW, Peretti GM, Bonassar LI, Gill TJ., Conditions affecting cell seeding onto three-dimensional scaffolds for cellular-based biodegradable implants. J Biomed Mar Res B Appl Biomater 2009; 91: 80-87.
35. Francioli SE, Candrian C, Martin K, Heberer M, Martin I, Barbero A., Effect of three-dimensional expansion and cell seeding density on the cartilage-forming capacity of human articular chondrocytes in type II collagen sponges. J Biomed Mater Res A 2010; 95: 924-931.
36. Dai W, Kawazoe N, Lin X, Dong J, Chen G., The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials 2010; 31: 2141-2152.
37. Ji W, Sun Y, van den Beuken JJ, Fan M, Chen Z, Jansen JA., Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharm Res 2011; 28: 1259-1272.
38. Chung HK, Park TG., Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Res 2007; 59: 249-262.
39. Majeti NV, Kumar R., Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci 2000; 3: 234-258.
40. Mourino V, Boccaccini AR., Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 2010; 7: 209-227.
41. Liu X, Zhao K, Gong T, Bao C, Weng J, Zhou S., Delivery of growth factors using a smart porous nanocomposite scaffold to repair a mandibular bone defect. Biomacromolecules 2014; 15: 1019-1030.
42. Ramteke KH, Jadhav VB, Dhole SN., Microspheres: As carriers used for novel drug delivery system. IOSR J Pharm 2012; 2: 44-48.
43. Saralidze K, Koole LH, Knetsch MLW., Polymeric microspheres for medical applications. Materials 2010; 3: 3537-3564.
44. Van Vlierberghe S, Dubruel P, Schacht E,. Biopolymer-based hydrogels as scaffolds for tissue engineering applications: A review. Biomacromolecules 2011; 12: 1387-1408.
45. Bindu S, Ashok V, Chatterjee A., Review on hydrogels as drug delivery in the pharmaceutical field. Int J Pharm Chem Sci 2012; 1: 642-661.
46. Huynh CT, Nguyen MK, Lee DS., Injectable block copolymer hydrogels: Achievements and future challenges for biomedical applications. Macromolecules 2011; 44: 6629-6636.
47. Wingard JR, Demetri GD,. Clinical applications of cytokines and growth factors. Dev Oncol 1999; 80: 407.[WorldCat]
48. Berrientos S, Stojaninovic O, Golinko MS, Brem H, Tomic-Canic M., Growth factors and cytokines in wound healing. Wound Rep Regen 2008; 16: 585-601.
49. Rose FR, Hou Q, Oreffo RO., Delivery systems for bone growth factors-The new players in skeletal regeneration. J Pharm Pharmacol 2004; 56: 415-427.
50. Vo TN, Kasper FK, Mikos AG., Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 2012; 64: 1292-1309.
51. Paolino D, Sinha P, Fresta M, Ferrari M., Drug delivery systems. In:, Webster JG, editor. Encyclopedia of Medical Devices and Instrumentation. Wiley Online Library; 2006.
52. Ganji F, Vasheghani-Farahani E., Hydrogels in controlled drug delivery systems. Iranian Poly J 2009; 18: 63-68.
53. Bindu S, Ashok V, Chatterjee A., Review on hydrogels as drug delivery in the pharmaceutical field. Int J Pharm Chem Sci 2012; 1: 642-661.
54. Suri SS, Hicham F, Singh, B., Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007; 2: 16-21.
55. Kamoun E., Alginate hydrogel as drug delivery system: Preparation of alginate hydrogel and its application as drug delivery system. VDM Verlag Dr. Muller; 2010.
56. Juhasz JA, Best SM, Bonfield W., Preparation of novel bioactive nano-calcium phosphate hydrogel composites. Sci Technol Adv Mater 2010; 11: 014103.
57. Antoine EE, Vlachos PP, Rylander MN., Review of collagen I hydrogels for bioengineered tissue microenvironments: Characterization of mechanics, structure, and transport. Tissue Eng Part B Rev 2014; 20: 683-696.
58. Burdick JA, Prestwich GD., Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011;32: H41-H56.
59. Kommireddy DA, Lvov Y, Mills DK., Nanoparticle multilayers: Surface modification for cell attachment and growth. J Biomed Nanotechnol 2005; 1: 286-290.
60. Kommireddy DA, Patel S, Shutava T, Mills DK, Lvov Y., Layer-by-layer assembly of TiO2 nanoparticles for stable hydrophilic biocompatible coatings. J Nanosci Nanotechnol 2005; 5: 1081-1087.
61. Karnik S., Bioactive hydrogels for TMJ repair. MS thesis: Louisiana Tech University; 2011.
62. Karnik SJ, Mills DK., Bioactive hydrogels for TMJ repair. FASEB J 2012; 26: 917.
63. Karnik S, Mills DK., Clay nanotubes as growth factor delivery vehicle for bone tissue engineering. J Nanomed Nanotechnol 2013; 4: 104.